TY - JOUR
T1 - Human Papillomavirus Immunization in Rural Primary Care
AU - Gunn, Rose
AU - Ferrara, Laura K.
AU - Dickinson, Caitlin
AU - Stock, Isabel
AU - Griffith-Weprin, Jennifer
AU - Wiser, Amy
AU - Hatch, Brigit
AU - Fagnan, L. J.
AU - Carney, Patricia A.
AU - Davis, Melinda M.
N1 - Funding Information:
The authors appreciate the time and insight of the clinic members and who participated in this research, as well as the patients and their families who were willing to be observed. Dr. Paul Darden and the Oregon Immunization Program staff were helpful in providing feedback and suggestions with interpreting the findings. In addition, the authors would like to acknowledge the work of Rex Larsen and Steele Valenzuela, who helped interpret ALERT Immunization Information System data. This study was supported by the American Cancer Society (RSG-18-022-01-CPPB). Dr. Davis’ time was supported in part by an NCI K07 award (1K07CA211971-01A1). The content provided is solely the responsibility of the authors and does not necessarily represent the official views of the funders. The IRB at Oregon Health & Sciences University approved this study on September 11, 2018 (# 18660). LJF, PAC, BH, and MMD designed the protocol and oversaw data collection. RG, LKF, IS, CD, and MMD collected data, iterated instruments, and analyzed data. AW, JG-W, RG, IS, CD, LKF, MMD, BH, LJF, and PAC contributed to the interpretation of the data and writing of the manuscript. Preliminary results of this study were presented at the 2019 Society for Applied Anthropology Annual Meeting and the 2019 North American Primary Care Research Group Annual Meeting. No financial disclosures were reported by the authors of this paper. Clinical Trials registration title: Increasing Human Papillomavirus (HPV) Immunization Rates: The Rural Adolescent Vaccine Enterprise (RAVE) #NCT03604393, registered July 27, 2018.
Funding Information:
The authors appreciate the time and insight of the clinic members and who participated in this research, as well as the patients and their families who were willing to be observed. Dr. Paul Darden and the Oregon Immunization Program staff were helpful in providing feedback and suggestions with interpreting the findings. In addition, the authors would like to acknowledge the work of Rex Larsen and Steele Valenzuela, who helped interpret ALERT Immunization Information System data. This study was supported by the American Cancer Society ( RSG-18-022-01-CPPB ). Dr. Davis’ time was supported in part by an NCI K07 award ( 1K07CA211971-01A1 ). The content provided is solely the responsibility of the authors and does not necessarily represent the official views of the funders. The IRB at Oregon Health & Sciences University approved this study on September 11, 2018 (# 18660 ). LJF, PAC, BH, and MMD designed the protocol and oversaw data collection.
Publisher Copyright:
© 2020 American Journal of Preventive Medicine
PY - 2020/9
Y1 - 2020/9
N2 - Introduction: Despite the safety and efficacy of the human papillomavirus vaccine, thousands are impacted by human papillomavirus and its related cancers. Rural regions have disproportionately low rates of human papillomavirus vaccination. Primary care clinics play an important role in delivering the human papillomavirus vaccine. A positive deviance approach is used to identify workflows, organizational factors, and communication strategies in rural clinics with higher human papillomavirus vaccine up-to-date rates. Positive deviance is a process by which exceptional behaviors and strategies are identified to understand factors that enable success. Methods: Rural primary care clinics were rank ordered by human papillomavirus vaccine up-to-date rates using 2018 Oregon Immunization Program data, then recruited via purposive sampling of clinics in the top and bottom quartiles. Two study team members conducted previsit interviews, intake surveys, and 2-day observation visits with 12 clinics and prepared detailed field notes. Data were collected October–December 2018 and analyzed using a thematic approach January–April 2019. Results: Four themes distinguished rural clinics with higher human papillomavirus vaccine up-to-date rates from those with lower rates. First, they implemented standardized workflows to identify patients due for the vaccine and had vaccine administration protocols. Second, they designated and supported a vaccine champion. Third, clinical staff in higher performing sites were comfortable providing immunizations regardless of visit type. Finally, they used clear, persuasive language to recommend or educate parents and patients about the vaccine's importance. Conclusions: Positive deviance identified characteristics associated with higher human papillomavirus vaccine up-to-date rates in rural primary care clinics. These findings provide guidance for rural clinics to inform human papillomavirus vaccination quality improvement interventions.
AB - Introduction: Despite the safety and efficacy of the human papillomavirus vaccine, thousands are impacted by human papillomavirus and its related cancers. Rural regions have disproportionately low rates of human papillomavirus vaccination. Primary care clinics play an important role in delivering the human papillomavirus vaccine. A positive deviance approach is used to identify workflows, organizational factors, and communication strategies in rural clinics with higher human papillomavirus vaccine up-to-date rates. Positive deviance is a process by which exceptional behaviors and strategies are identified to understand factors that enable success. Methods: Rural primary care clinics were rank ordered by human papillomavirus vaccine up-to-date rates using 2018 Oregon Immunization Program data, then recruited via purposive sampling of clinics in the top and bottom quartiles. Two study team members conducted previsit interviews, intake surveys, and 2-day observation visits with 12 clinics and prepared detailed field notes. Data were collected October–December 2018 and analyzed using a thematic approach January–April 2019. Results: Four themes distinguished rural clinics with higher human papillomavirus vaccine up-to-date rates from those with lower rates. First, they implemented standardized workflows to identify patients due for the vaccine and had vaccine administration protocols. Second, they designated and supported a vaccine champion. Third, clinical staff in higher performing sites were comfortable providing immunizations regardless of visit type. Finally, they used clear, persuasive language to recommend or educate parents and patients about the vaccine's importance. Conclusions: Positive deviance identified characteristics associated with higher human papillomavirus vaccine up-to-date rates in rural primary care clinics. These findings provide guidance for rural clinics to inform human papillomavirus vaccination quality improvement interventions.
UR - http://www.scopus.com/inward/record.url?scp=85087034316&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85087034316&partnerID=8YFLogxK
U2 - 10.1016/j.amepre.2020.03.018
DO - 10.1016/j.amepre.2020.03.018
M3 - Article
C2 - 32605866
AN - SCOPUS:85087034316
SN - 0749-3797
VL - 59
SP - 377
EP - 385
JO - American journal of preventive medicine
JF - American journal of preventive medicine
IS - 3
ER -